TargetMol

L-FMAC F-18

Product Code:
 
TAR-T24406
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T24406-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
L-FMAC F-18 has potential diagnostic activity during positron emission tomography (PET) imaging. After phosphorylation by DCK, the 18F moiety can be visualized by PET imaging.
CAS:
1134848-13-7
Formula:
C10H14FN3O4
Molecular Weight:
258.24
Purity:
0.98
SMILES:
Cc1cn([C@H]2O[C@@H](CO)[C@H](O)[C@H]2[18F])c(=O)nc1N

References

1. Cengiz A, Arda H?, D??er F, Yava?o?lu ?, Y?rekli Y, Bolaman AZ. Correlation between baseline 18F-FDG PET/CT findings and CD38, CD138 expressing myeloma cells in bone marrow and clinical parameters in patiens with multiple myeloma. Turk J Haematol. 2018 May 28. doi: 10.4274/tjh.2017.0372. [Epub ahead of print] PubMed PMID: 29806594. 2. Yan F, Li J, Wang HJ, Yang X, Yang JB, Tu XJ. [Impacts of different methods in laryngeal mask airway positioning on the airway management of elderly patients with general anesthesia]. Zhonghua Yi Xue Za Zhi. 2018 May 15;98(18):1424-1429. doi: 10.3760/cma.j.issn.0376-2491.2018.18.011. Chinese. PubMed PMID: 29804406. 3. Wolk DA, Sadowsky C, Safirstein B, Rinne JO, Duara R, Perry R, Agronin M, Gamez J, Shi J, Ivanoiu A, Minthon L, Walker Z, Hasselbalch S, Holmes C, Sabbagh M, Albert M, Fleisher A, Loughlin P, Triau E, Frey K, H?gh P, Bozoki A, Bullock R, Salmon E, Farrar G, Buckley CJ, Zanette M, Sherwin PF, Cherubini A, Inglis F. Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment. JAMA Neurol. 2018 May 14. doi: 10.1001/jamaneurol.2018.0894. [Epub ahead of print] PubMed PMID: 29799984. 4. Parsons S, Thomson W, Cresswell K, Starling B, McDonagh JE; Barbara Ansell National Network for Adolescent Rheumatology (BANNAR). What do young people with rheumatic conditions in the UK think about research involvement? A qualitative study. Pediatr Rheumatol Online J. 2018 May 24;16(1):35. doi: 10.1186/s12969-018-0251-z. PubMed PMID: 29793489.